Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 26 | 2022 | 946 | 2.990 |
Why?
|
Carcinoma, Pancreatic Ductal | 24 | 2024 | 1726 | 2.780 |
Why?
|
Pancreatic Neoplasms | 35 | 2024 | 5363 | 2.660 |
Why?
|
In Situ Hybridization | 14 | 2021 | 1900 | 1.310 |
Why?
|
Tumor Microenvironment | 21 | 2024 | 3873 | 1.300 |
Why?
|
Liver Diseases | 3 | 2020 | 1296 | 1.080 |
Why?
|
Adenocarcinoma, Mucinous | 3 | 2022 | 517 | 1.060 |
Why?
|
Colonic Neoplasms | 8 | 2024 | 2534 | 0.950 |
Why?
|
Carcinoma, Hepatocellular | 8 | 2024 | 2299 | 0.880 |
Why?
|
RNA, Satellite | 2 | 2022 | 17 | 0.860 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 2018 | 783 | 0.840 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 225 | 0.780 |
Why?
|
Liver Neoplasms | 9 | 2024 | 4321 | 0.770 |
Why?
|
Epithelial-Mesenchymal Transition | 9 | 2024 | 736 | 0.770 |
Why?
|
RNA, Neoplasm | 7 | 2019 | 749 | 0.750 |
Why?
|
Gene Expression Regulation, Neoplastic | 23 | 2024 | 8527 | 0.720 |
Why?
|
Epithelial Cells | 7 | 2020 | 3666 | 0.700 |
Why?
|
HMGA2 Protein | 1 | 2020 | 102 | 0.690 |
Why?
|
Adenocarcinoma | 13 | 2024 | 6332 | 0.610 |
Why?
|
Chimerism | 1 | 2019 | 155 | 0.600 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2019 | 953 | 0.560 |
Why?
|
Carcinoma, Papillary | 2 | 2024 | 784 | 0.560 |
Why?
|
Cell Line, Tumor | 34 | 2024 | 16966 | 0.550 |
Why?
|
Research Support as Topic | 1 | 2020 | 697 | 0.520 |
Why?
|
DNA, Satellite | 2 | 2015 | 67 | 0.500 |
Why?
|
Serum Albumin | 2 | 2015 | 675 | 0.500 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.490 |
Why?
|
RNA-Binding Proteins | 2 | 2021 | 1897 | 0.480 |
Why?
|
Colorectal Neoplasms | 8 | 2023 | 6901 | 0.480 |
Why?
|
Cholangiocarcinoma | 4 | 2022 | 552 | 0.420 |
Why?
|
Leucovorin | 7 | 2024 | 642 | 0.410 |
Why?
|
Neoplasm Metastasis | 8 | 2022 | 4908 | 0.410 |
Why?
|
Single-Cell Analysis | 9 | 2024 | 2448 | 0.380 |
Why?
|
RNA, Untranslated | 2 | 2015 | 459 | 0.380 |
Why?
|
Precancerous Conditions | 2 | 2017 | 978 | 0.380 |
Why?
|
Receptors, Androgen | 6 | 2018 | 1078 | 0.380 |
Why?
|
Sequence Analysis, RNA | 13 | 2024 | 2019 | 0.370 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4877 | 0.350 |
Why?
|
Mice, Inbred NOD | 6 | 2020 | 1825 | 0.340 |
Why?
|
Neoadjuvant Therapy | 9 | 2024 | 2823 | 0.340 |
Why?
|
MicroRNAs | 3 | 2020 | 3796 | 0.340 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.340 |
Why?
|
Fluorouracil | 7 | 2024 | 1637 | 0.330 |
Why?
|
Cell Separation | 6 | 2017 | 1722 | 0.330 |
Why?
|
Mice, SCID | 5 | 2022 | 2625 | 0.310 |
Why?
|
RNA, Messenger | 7 | 2022 | 12787 | 0.310 |
Why?
|
Bile Duct Neoplasms | 3 | 2022 | 605 | 0.310 |
Why?
|
Graft vs Tumor Effect | 1 | 2008 | 68 | 0.310 |
Why?
|
Humans | 122 | 2024 | 761326 | 0.310 |
Why?
|
RNA | 7 | 2022 | 2723 | 0.300 |
Why?
|
Coculture Techniques | 2 | 2024 | 1341 | 0.300 |
Why?
|
Barrett Esophagus | 2 | 2023 | 490 | 0.300 |
Why?
|
Interferons | 2 | 2022 | 705 | 0.290 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 10 | 2024 | 11735 | 0.290 |
Why?
|
Lymphocyte Transfusion | 1 | 2008 | 232 | 0.290 |
Why?
|
Long Interspersed Nucleotide Elements | 4 | 2023 | 330 | 0.280 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1726 | 0.270 |
Why?
|
Immunohistochemistry | 13 | 2024 | 11070 | 0.270 |
Why?
|
Transplantation Chimera | 2 | 2008 | 594 | 0.270 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2024 | 3590 | 0.260 |
Why?
|
DNA Mismatch Repair | 3 | 2024 | 428 | 0.250 |
Why?
|
DNA Methylation | 3 | 2017 | 4383 | 0.250 |
Why?
|
Stromal Cells | 3 | 2021 | 1330 | 0.250 |
Why?
|
Breast Neoplasms | 13 | 2022 | 21009 | 0.250 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.240 |
Why?
|
Transplantation Conditioning | 2 | 2008 | 1590 | 0.230 |
Why?
|
Cell Communication | 5 | 2024 | 1657 | 0.230 |
Why?
|
Mice | 32 | 2024 | 81474 | 0.230 |
Why?
|
Female | 62 | 2024 | 392485 | 0.230 |
Why?
|
Prognosis | 16 | 2024 | 29588 | 0.220 |
Why?
|
beta 2-Microglobulin | 1 | 2024 | 329 | 0.220 |
Why?
|
Animals | 38 | 2024 | 168388 | 0.220 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2024 | 5297 | 0.210 |
Why?
|
Organoplatinum Compounds | 2 | 2015 | 407 | 0.210 |
Why?
|
Alkylating Agents | 1 | 2023 | 133 | 0.210 |
Why?
|
Retroelements | 1 | 2023 | 163 | 0.210 |
Why?
|
GPI-Linked Proteins | 1 | 2024 | 468 | 0.200 |
Why?
|
Genomic Instability | 2 | 2016 | 709 | 0.200 |
Why?
|
Male | 53 | 2024 | 360621 | 0.200 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2022 | 214 | 0.200 |
Why?
|
RNA, Viral | 3 | 2021 | 2846 | 0.200 |
Why?
|
Microfluidics | 3 | 2017 | 653 | 0.200 |
Why?
|
Cell Differentiation | 3 | 2016 | 11531 | 0.190 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1647 | 0.190 |
Why?
|
Life Cycle Stages | 1 | 2022 | 160 | 0.190 |
Why?
|
Carcinoma | 2 | 2023 | 2328 | 0.190 |
Why?
|
Neuroendocrine Tumors | 2 | 2019 | 642 | 0.190 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2023 | 2911 | 0.190 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 6 | 2024 | 1089 | 0.190 |
Why?
|
Collagen Type I | 1 | 2024 | 616 | 0.190 |
Why?
|
Microfluidic Analytical Techniques | 3 | 2017 | 803 | 0.190 |
Why?
|
Organoids | 3 | 2024 | 740 | 0.180 |
Why?
|
Gene Expression Profiling | 6 | 2024 | 9414 | 0.180 |
Why?
|
Glioma | 3 | 2020 | 3455 | 0.180 |
Why?
|
Bone Neoplasms | 3 | 2019 | 2527 | 0.180 |
Why?
|
Microglia | 2 | 2020 | 1357 | 0.180 |
Why?
|
Lamivudine | 1 | 2022 | 365 | 0.180 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 56 | 0.180 |
Why?
|
Glioblastoma | 3 | 2020 | 3482 | 0.180 |
Why?
|
DNA, Neoplasm | 2 | 2019 | 1745 | 0.180 |
Why?
|
Endopeptidases | 1 | 2024 | 773 | 0.180 |
Why?
|
Wnt Proteins | 2 | 2015 | 718 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 6473 | 0.170 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2014 | 633 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 284 | 0.170 |
Why?
|
Endothelial Cells | 2 | 2024 | 3543 | 0.170 |
Why?
|
Tumor Cells, Cultured | 5 | 2021 | 6128 | 0.170 |
Why?
|
RNA Stability | 1 | 2021 | 331 | 0.160 |
Why?
|
Middle Aged | 32 | 2024 | 220774 | 0.160 |
Why?
|
Placenta Diseases | 1 | 2021 | 199 | 0.160 |
Why?
|
Lymphoma | 1 | 2008 | 1901 | 0.160 |
Why?
|
Brain Neoplasms | 4 | 2020 | 9030 | 0.160 |
Why?
|
Lipogenesis | 1 | 2020 | 214 | 0.160 |
Why?
|
Aged | 27 | 2024 | 169179 | 0.160 |
Why?
|
Prostatic Neoplasms | 8 | 2022 | 11116 | 0.160 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2019 | 53 | 0.160 |
Why?
|
Neoplasms | 7 | 2018 | 22158 | 0.160 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2152 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2021 | 461 | 0.160 |
Why?
|
Acetamides | 1 | 2020 | 256 | 0.160 |
Why?
|
Cell Movement | 4 | 2020 | 5202 | 0.150 |
Why?
|
Retroperitoneal Space | 1 | 2019 | 170 | 0.150 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
Ribosomes | 1 | 2021 | 501 | 0.150 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 117 | 0.150 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 117 | 0.150 |
Why?
|
DNA | 4 | 2022 | 7216 | 0.150 |
Why?
|
Facial Bones | 1 | 2019 | 208 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5670 | 0.150 |
Why?
|
DNA Contamination | 1 | 2017 | 18 | 0.150 |
Why?
|
DNA Damage | 2 | 2019 | 2442 | 0.150 |
Why?
|
Disease-Free Survival | 7 | 2021 | 6815 | 0.150 |
Why?
|
Forkhead Transcription Factors | 5 | 2022 | 1612 | 0.150 |
Why?
|
Ribosomal Proteins | 1 | 2020 | 371 | 0.150 |
Why?
|
Salivary Glands | 1 | 2019 | 229 | 0.150 |
Why?
|
Losartan | 1 | 2019 | 265 | 0.140 |
Why?
|
RANK Ligand | 1 | 2019 | 318 | 0.140 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3588 | 0.140 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 732 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2024 | 1355 | 0.140 |
Why?
|
Lamin Type B | 1 | 2016 | 26 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 617 | 0.140 |
Why?
|
Prolactin | 1 | 2019 | 625 | 0.140 |
Why?
|
Transforming Growth Factor beta | 2 | 2023 | 1959 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 367 | 0.140 |
Why?
|
beta-Globins | 1 | 2017 | 111 | 0.130 |
Why?
|
Androstenes | 1 | 2018 | 181 | 0.130 |
Why?
|
Cell Proliferation | 7 | 2021 | 10431 | 0.130 |
Why?
|
Macrophages | 3 | 2020 | 5768 | 0.130 |
Why?
|
Liposarcoma | 1 | 2019 | 285 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 828 | 0.130 |
Why?
|
Signal Transduction | 10 | 2024 | 23427 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 988 | 0.130 |
Why?
|
Mitotic Index | 1 | 2016 | 161 | 0.130 |
Why?
|
Mice, Nude | 3 | 2024 | 3603 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 82 | 0.130 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58946 | 0.130 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2016 | 120 | 0.130 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 169 | 0.120 |
Why?
|
Retinoblastoma Protein | 1 | 2019 | 671 | 0.120 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11098 | 0.120 |
Why?
|
Anus Neoplasms | 1 | 2019 | 329 | 0.120 |
Why?
|
Human papillomavirus 18 | 1 | 2015 | 125 | 0.120 |
Why?
|
Osteonectin | 1 | 2014 | 33 | 0.120 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 870 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.120 |
Why?
|
Centromere | 1 | 2015 | 213 | 0.120 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 78 | 0.120 |
Why?
|
Phenotype | 6 | 2023 | 16603 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1246 | 0.120 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 104 | 0.120 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1469 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1689 | 0.110 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 205 | 0.110 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 267 | 0.110 |
Why?
|
Adult | 21 | 2024 | 221122 | 0.110 |
Why?
|
User-Computer Interface | 1 | 2020 | 1399 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1157 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2021 | 1250 | 0.110 |
Why?
|
Graft vs Host Disease | 2 | 2023 | 3030 | 0.110 |
Why?
|
Gallbladder Neoplasms | 1 | 2015 | 190 | 0.110 |
Why?
|
RNA-Binding Protein EWS | 1 | 2014 | 210 | 0.110 |
Why?
|
Gold | 1 | 2017 | 478 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1249 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 628 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1989 | 0.100 |
Why?
|
Tissue Array Analysis | 3 | 2024 | 550 | 0.100 |
Why?
|
Lymph Nodes | 2 | 2023 | 3469 | 0.100 |
Why?
|
Metal Nanoparticles | 1 | 2017 | 396 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2014 | 337 | 0.100 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3428 | 0.100 |
Why?
|
DNA Transposable Elements | 1 | 2016 | 757 | 0.100 |
Why?
|
Lung | 2 | 2021 | 9994 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 575 | 0.100 |
Why?
|
Disease Progression | 4 | 2024 | 13500 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9275 | 0.090 |
Why?
|
Transfection | 1 | 2019 | 5776 | 0.090 |
Why?
|
Camptothecin | 1 | 2015 | 590 | 0.090 |
Why?
|
Microsatellite Instability | 1 | 2015 | 715 | 0.090 |
Why?
|
Placenta | 1 | 2020 | 1708 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 934 | 0.090 |
Why?
|
Proteomics | 2 | 2022 | 3843 | 0.090 |
Why?
|
Mutation | 9 | 2022 | 30044 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2573 | 0.090 |
Why?
|
Genes, BRCA1 | 1 | 2014 | 764 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 611 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2019 | 1605 | 0.090 |
Why?
|
Genome, Human | 1 | 2023 | 4423 | 0.090 |
Why?
|
Biopsy | 5 | 2023 | 6768 | 0.090 |
Why?
|
Pancreatectomy | 3 | 2021 | 810 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2022 | 2052 | 0.090 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2012 | 410 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1805 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2019 | 4280 | 0.080 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 3793 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5665 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3685 | 0.080 |
Why?
|
Up-Regulation | 4 | 2020 | 4120 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2022 | 3057 | 0.080 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 223 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4414 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 940 | 0.080 |
Why?
|
Transcription Factors | 2 | 2022 | 12122 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3075 | 0.080 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1611 | 0.080 |
Why?
|
Heterochromatin | 1 | 2011 | 293 | 0.080 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2022 | 296 | 0.080 |
Why?
|
Mucins | 2 | 2022 | 568 | 0.080 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5778 | 0.080 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2014 | 0.080 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4810 | 0.080 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6478 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1742 | 0.070 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13635 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1262 | 0.070 |
Why?
|
DNA Replication | 1 | 2014 | 1418 | 0.070 |
Why?
|
Serine Endopeptidases | 2 | 2024 | 1021 | 0.070 |
Why?
|
Disease Models, Animal | 6 | 2023 | 18234 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39108 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1410 | 0.070 |
Why?
|
Fibroblasts | 3 | 2024 | 4139 | 0.070 |
Why?
|
Steroids | 2 | 2023 | 928 | 0.070 |
Why?
|
Autopsy | 2 | 2020 | 1006 | 0.070 |
Why?
|
RNA Interference | 1 | 2014 | 2832 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2556 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1974 | 0.060 |
Why?
|
Histones | 1 | 2016 | 2579 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2018 | 22124 | 0.060 |
Why?
|
Chromatin | 2 | 2015 | 2960 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2024 | 64645 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 791 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1994 | 0.060 |
Why?
|
Automation, Laboratory | 2 | 2015 | 103 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2020 | 14409 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2804 | 0.060 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15262 | 0.060 |
Why?
|
Fibrosis | 2 | 2024 | 2048 | 0.060 |
Why?
|
Immunity | 2 | 2021 | 997 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7597 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2223 | 0.060 |
Why?
|
Cadherins | 2 | 2022 | 904 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10760 | 0.060 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2023 | 41 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2015 | 2985 | 0.060 |
Why?
|
Neuropilin-1 | 1 | 2024 | 90 | 0.060 |
Why?
|
Gallium Radioisotopes | 1 | 2024 | 195 | 0.060 |
Why?
|
Lymph Node Excision | 2 | 2023 | 1273 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1610 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13333 | 0.050 |
Why?
|
Arylsulfotransferase | 1 | 2023 | 27 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9319 | 0.050 |
Why?
|
Alu Elements | 1 | 2023 | 115 | 0.050 |
Why?
|
Brain | 2 | 2020 | 27103 | 0.050 |
Why?
|
Gene Expression | 2 | 2019 | 7582 | 0.050 |
Why?
|
Minisatellite Repeats | 1 | 2023 | 164 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7389 | 0.050 |
Why?
|
Neoplastic Processes | 1 | 2022 | 35 | 0.050 |
Why?
|
Ligands | 2 | 2022 | 3271 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2811 | 0.050 |
Why?
|
Phosphorylation | 3 | 2019 | 8312 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
Sulfotransferases | 1 | 2023 | 149 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3200 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2017 | 1698 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4764 | 0.050 |
Why?
|
Cell Line | 4 | 2019 | 15599 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5706 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 24 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 197 | 0.050 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2021 | 46 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2891 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4936 | 0.050 |
Why?
|
RNA Splicing | 2 | 2016 | 917 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22154 | 0.050 |
Why?
|
Genes, MHC Class I | 1 | 2021 | 240 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2020 | 149 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5794 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4022 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1153 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2021 | 785 | 0.040 |
Why?
|
Phlebitis | 1 | 2019 | 35 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2693 | 0.040 |
Why?
|
Survival Rate | 2 | 2016 | 12710 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2020 | 271 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2859 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 310 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 67 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 330 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 396 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36430 | 0.040 |
Why?
|
Immunotherapy | 3 | 2021 | 4649 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 421 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 361 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2021 | 80575 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2007 | 1598 | 0.040 |
Why?
|
E2F Transcription Factors | 1 | 2019 | 269 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 113 | 0.040 |
Why?
|
Herpesviridae | 1 | 2019 | 106 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 656 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 555 | 0.040 |
Why?
|
Germany | 1 | 2020 | 875 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2560 | 0.040 |
Why?
|
Smad4 Protein | 1 | 2019 | 191 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1519 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1560 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2022 | 1062 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 277 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9534 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 111 | 0.040 |
Why?
|
Blood Preservation | 1 | 2017 | 168 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 321 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 497 | 0.030 |
Why?
|
RNA Probes | 1 | 2016 | 111 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 597 | 0.030 |
Why?
|
Hematoxylin | 1 | 2016 | 60 | 0.030 |
Why?
|
Cytoprotection | 1 | 2017 | 200 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2016 | 69 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 287 | 0.030 |
Why?
|
Anal Canal | 1 | 2019 | 373 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 597 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2504 | 0.030 |
Why?
|
Tumor Escape | 1 | 2019 | 370 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 529 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2017 | 379 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10075 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 261 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 599 | 0.030 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 227 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2007 | 1896 | 0.030 |
Why?
|
Risk Assessment | 3 | 2021 | 23981 | 0.030 |
Why?
|
gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1385 | 0.030 |
Why?
|
Radiotherapy | 1 | 2021 | 1499 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5792 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 7954 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2650 | 0.030 |
Why?
|
Arginase | 1 | 2015 | 80 | 0.030 |
Why?
|
Spiral Cone-Beam Computed Tomography | 1 | 2015 | 34 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9351 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3210 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2020 | 938 | 0.030 |
Why?
|
Platelet Activation | 1 | 2017 | 645 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2014 | 189 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1887 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 2015 | 1306 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 502 | 0.030 |
Why?
|
Surface Properties | 1 | 2017 | 1160 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 629 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1791 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3076 | 0.030 |
Why?
|
Coloring Agents | 1 | 2016 | 559 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 496 | 0.030 |
Why?
|
England | 1 | 2015 | 527 | 0.030 |
Why?
|
Centrosome | 1 | 2014 | 209 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9474 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1371 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3489 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7238 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2060 | 0.030 |
Why?
|
Wnt2 Protein | 1 | 2012 | 28 | 0.030 |
Why?
|
Contact Inhibition | 1 | 2012 | 46 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2018 | 1093 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1908 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2023 | 3027 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 696 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2468 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2914 | 0.030 |
Why?
|
Hepatitis B, Chronic | 1 | 2017 | 410 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 368 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 435 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 18962 | 0.030 |
Why?
|
Wilms Tumor | 1 | 2015 | 379 | 0.020 |
Why?
|
Collagen | 1 | 2020 | 2638 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3512 | 0.020 |
Why?
|
Cell Shape | 1 | 2013 | 371 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 716 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2021 | 2445 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12972 | 0.020 |
Why?
|
Time Factors | 2 | 2016 | 39974 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3122 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3330 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4740 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1656 | 0.020 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 508 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 624 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2712 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1054 | 0.020 |
Why?
|
Methylation | 1 | 2013 | 1082 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 255 | 0.020 |
Why?
|
Poly T | 1 | 2010 | 6 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1355 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 12982 | 0.020 |
Why?
|
Workflow | 1 | 2015 | 851 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 560 | 0.020 |
Why?
|
Reverse Transcription | 1 | 2010 | 47 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2612 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 370 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1118 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4567 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 54405 | 0.020 |
Why?
|
Culture | 1 | 2014 | 623 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 971 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3089 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20092 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2014 | 581 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 898 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9180 | 0.020 |
Why?
|
Mesoderm | 1 | 2013 | 673 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1370 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2644 | 0.020 |
Why?
|
Tamoxifen | 1 | 2014 | 965 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1403 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2013 | 719 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 2821 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11900 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 29858 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1753 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2137 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1670 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2509 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6034 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1835 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2201 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2019 | 1157 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 774 | 0.020 |
Why?
|
Paclitaxel | 1 | 2016 | 1732 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2413 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1114 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3572 | 0.020 |
Why?
|
Prostatectomy | 1 | 2016 | 1824 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2803 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2556 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 748 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 59196 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3639 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 1770 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7852 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41440 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4550 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3025 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20555 | 0.020 |
Why?
|
United States | 3 | 2021 | 72317 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2248 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1669 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10191 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1934 | 0.020 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2007 | 225 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4173 | 0.020 |
Why?
|
Breast | 1 | 2014 | 1966 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 2007 | 719 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7390 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4482 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3638 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 629 | 0.010 |
Why?
|
Antigens, CD | 1 | 2015 | 4000 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12449 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2015 | 3060 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4509 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9333 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 2115 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13251 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3777 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4576 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12450 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4063 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8635 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4246 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17872 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36202 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42251 | 0.010 |
Why?
|
Family | 1 | 2007 | 3197 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8470 | 0.010 |
Why?
|
Child | 1 | 2019 | 80156 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 88305 | 0.010 |
Why?
|